Related references
Note: Only part of the references are listed.Australian recommendations for the management of hepatocellular carcinoma: a consensus statement
John S. Lubel et al.
MEDICAL JOURNAL OF AUSTRALIA (2021)
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
A. Vogel et al.
ANNALS OF ONCOLOGY (2021)
Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma
Dan Su et al.
JAMA NETWORK OPEN (2021)
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
Masatoshi Kudo et al.
LIVER CANCER (2021)
Epidemiology and risk-stratification of NAFLD-associated HCC
George N. Ioannou
JOURNAL OF HEPATOLOGY (2021)
Hepatobiliary Cancers, Version 2.2021
Al B. Benson III et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
L-T Chen et al.
ANNALS OF ONCOLOGY (2020)
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights
Di-Yang Xie et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Indian Council of Medical Research consensus document on hepatocellular carcinoma
Bhawna Sirohi et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2020)
Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma
Saleh A. Alqahtani et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2020)
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations
Ashish Kumar et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2020)
A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial).
Namiki Izumi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update
Norihiro Kokudo et al.
HEPATOLOGY RESEARCH (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)
Jian Zhou et al.
LIVER CANCER (2018)
Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis
Thomas Worland et al.
JOURNAL OF GASTROINTESTINAL CANCER (2018)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines from 2001 to 2017
Peipei Song et al.
BIOSCIENCE TRENDS (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Comments on Liver resection using total vascular exclusion of the liver preserving the caval flow, in situ hypothermic portal perfusion and temporary porta-caval shunt: a new technique for central tumors
Daniele Sommacale et al.
HEPATOBILIARY SURGERY AND NUTRITION (2017)
Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm
Mandy Richani et al.
ANNALS OF HEPATOLOGY (2016)
Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
Takeshi Terashima et al.
HEPATOLOGY RESEARCH (2016)
2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma
Joong-Won Park et al.
KOREAN JOURNAL OF RADIOLOGY (2015)
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Mohsen Naghavi et al.
LANCET (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects
Peipei Song et al.
BIOSCIENCE TRENDS (2014)
Sorafenib for advanced-stage hepatocellular carcinoma
Ciprian Tomuleasa et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Radiofrequency Ablation versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas 2 cm or Smaller: A Retrospective Comparative Study
Zhen-Wei Peng et al.
RADIOLOGY (2012)
Hypervascular Hepatocellular Carcinoma 1 cm or Smaller in Patients With Chronic Liver Disease: Characterization With Gadoxetic Acid-Enhanced MRI That Includes Diffusion-Weighted Imaging
Ji-Eun Kim et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
J. -L. Raoul et al.
CANCER TREATMENT REVIEWS (2011)
Anatomic Pathology of Hepatocellular Carcinoma: Impact on Prognosis and Response to Therapy
Tania Roskams
CLINICS IN LIVER DISEASE (2011)
Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy
Augusto Villanueva et al.
ANNUAL REVIEW OF MEDICINE (2010)
Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials
Tao Zhang et al.
ANTI-CANCER DRUGS (2010)
Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
Anna S. Lok et al.
GASTROENTEROLOGY (2010)
Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
Riad Salem et al.
GASTROENTEROLOGY (2010)
Hepatocellular Carcinoma (HCC) A Global Perspective
Peter Ferenci et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting
Melanie B. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
Valentina Santi et al.
JOURNAL OF HEPATOLOGY (2010)
Will Gd-EOB-MRI Change the Diagnostic Algorithm in Hepatocellular Carcinoma?
Masatoshi Kudo
ONCOLOGY (2010)
Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis
Morris Sherman
SEMINARS IN LIVER DISEASE (2010)
A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization
R. J. Lewandowski et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Highlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives
Raffaele Addeo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
Donald Poon et al.
LANCET ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
Takeaki Ishizawa et al.
GASTROENTEROLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
Tito Livraghi et al.
HEPATOLOGY (2008)
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
Alejandro Forner et al.
HEPATOLOGY (2008)
Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-Expanded criteria based on preoperative imaging
F. Y. Yao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis
George N. Ioannou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Consensus and controversy in the management of hepatocellular carcinoma
Robin D. Kim et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients
Kenichi Takayasu et al.
GASTROENTEROLOGY (2006)
A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus
E Santagostino et al.
BLOOD (2003)
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
SD Ryder
GUT (2003)
Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study
BJ McMahon et al.
HEPATOLOGY (2000)
Share Paper
